NPI: 1538487897 · KISSIMMEE, FL 34759 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/12/2010
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/12/2010 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,962 | $4.34M |
| 2019 | 27,702 | $4.35M |
| 2020 | 25,766 | $3.99M |
| 2021 | 17,119 | $1.19M |
| 2022 | 10,246 | $935K |
| 2023 | 4,639 | $413K |
| 2024 | 1,445 | $139K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 36,409 | 1,869 | $4.90M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 32,495 | 2,409 | $4.64M |
| J1270 | Injection, doxercalciferol, 1 mcg | 18,632 | 1,335 | $2.54M |
| A4657 | Syringe, with or without needle, each | 5,435 | 1,761 | $1.05M |
| J1756 | Injection, iron sucrose, 1 mg | 7,008 | 1,419 | $745K |
| 83550 | 1,519 | 963 | $230K | |
| 83540 | 1,513 | 960 | $230K | |
| 82728 | 1,520 | 968 | $228K | |
| 85041 | 1,604 | 1,051 | $224K | |
| 85048 | 1,604 | 1,051 | $224K | |
| 83970 | 1,198 | 754 | $214K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 531 | 244 | $87K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 285 | 206 | $48K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 26 | 13 | $9K |
| 90674 | 51 | 38 | $7K | |
| G0008 | Administration of influenza virus vaccine | 49 | 39 | $5K |